F. Hoffmann-La Roche Pharmaceuticals

F. Hoffmann-La Roche AG, commonly known as Roche, is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The company was founded in 1896 by Fritz Hoffmann-La Roche in Basel, Switzerland. From its inception, the brand was built on the principle of industrial manufacturing of standardized medicines, which was a revolutionary concept at the time. Roche has since grown into one of the largest biotech companies in the world.

Today, Roche operates with a dual focus on pharmaceuticals and diagnostics, holding a leading position in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The company's manufacturing footprint is truly global, with major production facilities located in Switzerland, Germany, the United States, and several other locations across Europe and Asia to ensure the delivery of critical medicines and diagnostic tests to patients worldwide.

Roche is a publicly traded company, though the founding family still holds a majority of the voting rights, maintaining a long-term perspective on the company's research and development. The brand has expanded significantly through strategic acquisitions, most notably the full integration of Genentech in the United States, which further solidified its leadership in the biotechnology sector. The company's headquarters remains in Basel, Switzerland, where it continues to drive innovation in personalized healthcare.